πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6060505

Method of treating cancer using C-26 modified bryostatin

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6057125

Clock gene and gene product

The Board of Trustees of Northwestern University Β· Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6057104

Disruption of the mammalian Rad51 protein and disruption of proteins that associate with m

Lexicon Genetics, Inc. Β· Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6056968

Pharmaceutical drug dosage forms providing different release rates

Darwin Discovery Limited Β· Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6056952

Selective elimination of T cells that recognize specific preselected targets

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6057311

Benzodiazonine derivatives binding to cholecystokinin or gastrin receptors

The James Black Foundation Limited Β· Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6057346

Inhibition of retroviral LTR promoters by calcium response modifiers

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6057421

Variable heavy and light chain regions of murine monoclonal antibody 1F7

Immpheron, Inc. Β· Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6057341

Bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma Β· Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6057300

Methods for treating cancers and restenosis with p21

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6057298

Keratin K1 expression vectors and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6057158

Adenovirus vectors

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6054472

Inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6054567

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic meth

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6054560

Mitogen activated protein kinase, FRK

The Regents of the University of California Β· Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6054486

Use of 9-Deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-d

UNITED TECHNOLOGY CORPORATION Β· Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6054485

Eye treatments using synthetic thyroid hormone compositions

The Regents of the University of California Β· Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6054449

Compounds and method for PDT of intimal hyperplasia and other diseases

Miravant Pharmaceuticals, Inc. Β· Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6054442

Methods and compositions for modulation and inhibition of telomerase in vitro

The Board of Regents of the University of Texas System Β· Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6054433

Methods and compositions for stimulating tissue growth and epithelial moisturization

The Regents of the University of California Β· Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6054427

Methods and compositions for optimization of oxygen transport by cell-free systems

The Regents of the University of California Β· Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6054293

Semaphorin receptors

The Regents of the University of California Β· Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6054133

Anti-microbial targeting for intracellular pathogens

The Regents of the University of California Β· Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6051396

Method for producing retinoblastoma gene protein products

The Regents of the University of California Β· Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired